tubocurarine has been researched along with furosemide in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Giacomini, KM; Huang, Y; Khuri, N; Kido, Y; Kosaka, A; Morrissey, KM; Sali, A; Wittwer, MB; Zhang, X; Zur, AA | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Matteo, RS; Miller, RD; Sohn, YJ | 1 |
| Appelt, GD; Reyes, E | 1 |
| Simmonds, MA | 1 |
| Dretchen, KL; Ham, JA; Miller, RD; Scappaticci, KA; Sohn, YJ | 1 |
7 other study(ies) available for tubocurarine and furosemide
| Article | Year |
|---|---|
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling.
Topics: Computer Simulation; Fluorescent Dyes; Organic Cation Transport Proteins; Prescription Drugs | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Enhancement of d-tuborcurarine neuromuscular blockade by diuretics in man.
Topics: Adolescent; Adult; Drug Synergism; Evoked Potentials; Furosemide; Humans; Kidney Transplantation; Male; Mannitol; Neuromuscular Blocking Agents; Synaptic Transmission; Transplantation, Homologous; Tubocurarine | 1976 |
Pharmacological aspects of concurrent administration of furosemide and skeletal muscle relaxants.
Topics: Animals; Blood Pressure; Chlordiazepoxide; Diaphragm; Diuresis; Drug Combinations; Drug Interactions; Electric Stimulation; Female; Furosemide; Hydrogen-Ion Concentration; Male; Muscles; Neuromuscular Nondepolarizing Agents; Osmolar Concentration; Phrenic Nerve; Potassium; Rats; Sodium; Succinylcholine; Tubocurarine | 1972 |
Classification of some GABA antagonists with regard to site of action and potency in slices of rat cuneate nucleus.
Topics: Animals; Bicuculline; Cyclic P-Oxides; Furosemide; GABA Antagonists; In Vitro Techniques; Medulla Oblongata; Organophosphorus Compounds; Pentylenetetrazole; Picrotoxin; Rats; Receptors, Cell Surface; Receptors, GABA-A; Strychnine; Tubocurarine | 1982 |
Effects of furosemide on the neuromuscular junction.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Cats; Dose-Response Relationship, Drug; Furosemide; Male; Muscle Contraction; Neuromuscular Junction; Rats; Rats, Inbred Strains; Sodium Fluoride; Synaptic Transmission; Theophylline; Tubocurarine | 1982 |